Ibrahim. H. Eissa

Dr. Ibrahim. H. Eissa

Al Azhar University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2021 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy
Mohammed Ahmed DahabMohammed Ahmed Dahab
Mohammed Ahmed Dahab
Ahmed MetwalyAhmed Metwaly
Ahmed Metwaly
Sameh S. ElhadySameh S. Elhady
Sameh S. Elhady
Eslam B. ElkaeedEslam B. Elkaeed
Eslam B. Elkaeed
KDKhaled M. Darwish
Khaled M. Darwish
The rapid and global spread of a new human coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has produced an immediate urgency to discover promising targets for the treatment of COVID-19. Here, we consider drug repurposing as an attractive approach that can facilitate the drug discovery process by repurposing existing pharmaceuticals to treat illnesses other than their primary indications. We review current information concerning the global health issue of COVID-19 including promising approved drugs, e.g., human angiotensin-converting enzyme inhibitors (hACEIs). Besides, we describe computational approaches to be used in drug repurposing and highlight examples of in-silico studies of drug development efforts against SARS-CoV-2. Alacepril and lisinopril were found to interact with human angiotensin-converting enzyme 2 (hACE2), the host entranceway for SARS-CoV-2 spike protein, through exhibiting the most acceptable rmsd_refine values and the best binding affinity through forming a strong hydrogen bond with Asn90, which is assumed to be essential for the activity, as well as significant extra interactions with other receptor-binding residues. Furthermore, molecular dynamics (MD) simulations followed by calculation of the binding free energy were also carried out for the most promising two ligand-pocket complexes from docking studies (alacepril and lisinopril) to clarify some information on their thermodynamic and dynamic properties and confirm the docking results as well. These results we obtained probably provided an excellent lead candidate for the development of therapeutic drugs against COVID-19. Eventually, animal experiments and accurate clinical trials are needed to confirm the potential preventive and treatment effect of these compounds.


19 June 2021 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
Ahmed MetwalyAhmed Metwaly
Ahmed Metwaly
MGMohammed M. Ghoneim
Mohammed M. Ghoneim
Ibrahim. H. EissaIbrahim. H. Eissa
Ibrahim. H. Eissa
IEIslam A. Elsehemy
Islam A. Elsehemy
AMAhmad Mostafa
Ahmad Mostafa
DDDe qiang Dou
De qiang Dou
The ancient Egyptians practiced medicine with highly professional methods. They had advanced knowledge of anatomy and surgery. Also, they treated a lot of diseases including dental, gynecological, gastrointestinal, and urinary disorders. They could diagnose diabetes and cancer. The used therapeutics extended from different plants to include several animal products and minerals. Some of these plants are still used in the present day. Fortunately, they documented their life details by carving on stone, clay, or papyri. Although a lot of these records have been lost or destroyed, the surviving documents represent a huge source of knowledge in different scientific aspects including medicine. This review article is an attempt to understand some information about traditional medicine in ancient Egypt, we will look closely at some basics, sources of information of Egyptian medicine in addition to common treated diseases and therapeutics in this great civilization.

1 January 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
HMHazem A. Mahdy
Hazem A. Mahdy
MIMohammed K. Ibrahim
Mohammed K. Ibrahim
Ahmed MetwalyAhmed Metwaly
Ahmed Metwaly
ABAmany Belal
Amany Belal
AMAhmed B.M. Mehany
Ahmed B.M. Mehany
Ibrahim. H. EissaIbrahim. H. Eissa
Ibrahim. H. Eissa